The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kartashov V.A.

Kafedra farmatsii Maĭkopskogo gosudarstvennogo tekhnologicheskogo universiteta, Maĭkop, Rossiia, 385000

Chernova L.V.

Institute of Pharmacy of Sechenov First State Medical University, Moscow, Russia, Chair of Pharmaceutical Technology, Moscow, Russia

The detection of quentiapine and olanzapine in the biological objects

Authors:

Kartashov V.A., Chernova L.V.

More about the authors

Journal: Forensic Medical Expertise. 2014;57(5): 47‑52

Read: 21667 times

Contact the author
Table of contents

THE DETECTION OF QUENTIAPINE AND OLANZAPINE IN THE BIOLOGICAL OBJECTS
THE DETECTION OF QUENTIAPINE AND OLANZAPINE IN THE BIOLOGICAL OBJECTS

To cite this article:

Kartashov VA, Chernova LV. The detection of quentiapine and olanzapine in the biological objects. Forensic Medical Expertise. 2014;57(5):47‑52. (In Russ.)

Подписка 2026 Судебно-медицинская экспертиза (Forensic Medical Expertise)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Sales of anti­psychotics and anti­convulsants in the Russian Fede­ration for the period 2019—2024. Medi­cal Technologies. Asse­ssment and Choice. 2026;(1):134-142
Meta­bolic correction of systemic oxidative-toxic lesions in urgent abdo­minal surgery. Piro­gov Russian Journal of Surgery. 2026;(3):63-70
Abstract:

Keywords:

quentiapine
olanzapine
intoxication
biological objects
analytical methods.
quentiapine
olanzapine
intoxication
biological objects
analytical methods.
quentiapine
olanzapine
intoxication
biological objects
analytical methods.
quentiapine
olanzapine
intoxication
biological objects
analytical methods.

Authors:

Kartashov V.A.

Kafedra farmatsii Maĭkopskogo gosudarstvennogo tekhnologicheskogo universiteta, Maĭkop, Rossiia, 385000

Chernova L.V.

Institute of Pharmacy of Sechenov First State Medical University, Moscow, Russia, Chair of Pharmaceutical Technology, Moscow, Russia

Close metadata

References:

  1. Meditsinsky spravochnik. Atipichnye neiroleptiki [The Medical reference book. Non-typical neuroleptics]. http://doctorspb.ru/articles.php?articleid=1055.
  2. Mashkovsky M.D. Lekarstvennye sredstva . Izd. 16-e [The medicinal preparations. The 16th edition]. M: Novaya volna 2010.
  3. Tsygankov B.D., Agasaryan E.G. Sovremennye I klassicheskie antipsikhoticheskie preparaty: sravnitel'ny analiz effektivnosti I bezopasnosti [The modern and classical antipsychotic preparations: the comparative analysis of the effectiveness and safety]. Psikhiatr I psikhofarmakoterap 2006; 6: 631-637.
  4. Danilov D.S. Vliyanie pobochnykh yavleniy I oslozhneniy, vyzyvaemykh atipichnymi neiroleptikami, na effektivnost' terapii u bol'nykh shizofreniey [The influence of adverse effects caused by non-typical neuroleptics on the effectiveness of therapy of the patients presenting with schizophrenia]. Nevrol I psikhiatr 2010; 3: 48-54.
  5. Danilov D.S. Korrelyatsiya ozhireniya, svyazannogo s priyomom atipichnykh neiroleptikov, y bol'nykh shizofreniey (otsenka tselesoobraznosti perevoda bol'nykh na tipichnye antipsikhoticheskie preparaty) [The correlation between obesity and the intake of non-typical neuroleptics in the patients presenting with schizophrenia (the estimation of the desirability of the transition of the patients to the intake of typical antipsychotic preparations)]. Psikhiatr i psikhofarmakoterap 2007; 6: 10-14.
  6. Danilov D.S. Effektivnost' terapii shizofrenii atipichnymi neiroleptikami (znachenie razlichnykh kliniko-sotsial'nykh faktorov): Avtoref. diss. … d-ra med. nauk [The effectiveness of the treatment of schizophrenia with non-typical neuroleptics (the importance of various clinical and social factors): Synopsis of the thesis for … doctor med. sci. degree]. M 2011
  7. Sermyak M.J., Leslie D.L., Alarcon R.D., Losonczy M.F., Rosenchek R. Связь сахарного диабета с употреблением атипичных нейролептиков при лечении шизофрении. Am J Psychiat 2002; 159: 561-566.
  8. Huybrecht K.F., Gerhard T., Crystal S., Olfson M., Avorn J., Levin R., Lucus J., Schneeweiss S. Comparison of different approaches to confounding adjustment in a study on the association of antipsychotic medication with mortality in older nursing home patients. Am J Epidemiol 2011; 174: 9: 1089-1099.
  9. Mingazov A.A. Sluchay smerti ot otravleniya kvetiapinom [A case of death from quetiapine intoxication]. Probl ekspert v med 2007; 3: 62-63.
  10. Fernandes P.P., Marcil W.A. Death Associated With Quetiapine Overdose. Am J Psychiat 2002; 159: 12: 2114.
  11. Mel'nik A.A., Grigor'ev A.M., Azarova L.V. Opredelenie kvetiapina, ego proizvodnykh I metabolitov metodami gazo-zhidkostnoy, khromato-mass-spektrometrii I vysokoeffektivnoy zhidkostnoy khromatografii v biologicheskikh obraztsakh [The determination of quetiapine, its metabolites, and derivatives by the methods of gas-liquid, chromate-mass-spectrometry, and high performance liquid chromatography in biological specimens]. Sorbts I khromatogr protsessy 2010; 1: 35-46.
  12. Lazaryan D.S., Vergeichik T.Kh., Linnikova V.A., Gus'kova G.B., Tsybulina M.G. Ispol'zovanie khromatograficheskikh metodov dlya obnaruzheniya I kolichestvennogo opredeleniya kvetiapina fumarata v moche. Razrabotka, issledovanie I marketing novoy farmatsevticheskoy produktsii. V kn.: Sbornik nauchnykh trudov [The application of chromatographic techniques for the detection and quantitative determination of quetiapine fumarate in the urea. The development, investigation, and marketing of the new pharmaceutical products. In: The volume of scientific works]. Pyatigorsk: Pyatigorskaya farmakademiya 2008; 63: 287-289.
  13. Vergeichik T.Kh., Linnikova V.A., Lazaryan D.S., Gus'kova G.B., Tsybulina M.G. Obnaruzhenie I opredelenie metoprolola, kvetiapina I flupertina v trupnoy pecheni posle izolirovaniya vodoy podkislennoy [The detection and determination of metropolol, quetiapine, and flupertine in the cadaveric liver following isolation with acidified water]. Pyatigorsk: Pyatigorskaya farmakademiya 2009; 64: 282-284.
  14. Vergeichik T.Kh., Linnikova V.A., Gus'kova G.B., Sarkisyan M.S., Lazaryan D.S. Razrabotka metodik izolirovaniya, obnaruzheniya I opredeleniya kvetiapina v krovi [The development of the methods for the isolation, detection, and determination of quetiapine in blood]. Pyatigorsk: Pyatigorskaya farmakademiya 2010; 65: 288-290.
  15. Vergeichik T.Kh., Linnikova V.A., Gus'kova, Sarkisyan M.S. Obnaruzhenie I opredelenie kvetiapina v izvlecheniaykh iz pochek pri khiniko-toksikologicheskom analize [The detection and determination of quetiapine in the extracts from the kidneys during the chemical toxicological analysis]. Pyatigorsk: Pyatigorskaya farmakademiya 2011; 66: 369-371.
  16. Young A.C., Kleinschmidt K.C., Wax P.M. Late-onset seizures associated with quetiapine poisoning. J Med Toxicol 2011; 5: 1: 24-26.
  17. Parker D.R., Mcinture L.M. Case studies of postmortem quetiapine: Therapeutic or toxic concentrations? Congress Joint Meeting of the Society of forensic Toxicologists and the International Ass Forens Toxicol 2005; 29: 5: 407-412.
  18. Flarnmia D.D., Valouch T., Venuti S. Tissue Distribution of Quetiapine in 20 Cases in Virginia. J Analit Toxicol 2006; 30: 287-292.
  19. Wise S.B.S., Jenkins A.J. Disposition of Quetiapine in Biological Specimens from Postmortem Cases. J Forens Sci 2005; 50: 1: 200-205.
  20. Bellomarino S.A., Brown A.J., Conlan X.A., Bamett N.W. Preliminary evaluation of monolithic column high-performance liquid chromatography with tris(2,2'-bipyridil) ruthenium (II) chemiluminescence detection for the determination of quetiapine in human body fluids. Talanta 2009; 77: 5: 1873-1876.
  21. www.chem.agilent.com/Library/Applications/5990-8169EN.pdf.
  22. Kun-yan L.I., Ze-neng C.H.E.N.G., Xin L.I., Xue-lian B.A.I., Bi-kui Z.H.A.N.G., Huan-de L.I. Simeltaneous determination of quetiapine and three metabolites in human plasma by high-performance liquid chromatography - electrospray ionization mass spectrometry. Acta Pharmacol Sin 2004; 25: 1: 110-114.
  23. Ryh-Nan Pan, B.Pei-Chung Kuo, Li-Heng Pao.  Validated LC-MC-MC method for determination of quetiapine in human plasma: application to a pharmacokinetic study. J Chromatog Sci 2012; 50: 3: 277-282.
  24. http://en.cnki.com.cn/Article_en/CJFDTOTAL-ZGYZ200211012.htm.
  25. Barrett B., Holcapek M., Huclova J., Borek-Dohalsky V., Fejt P., Nemec B., Jelinek I. Validated HPTLC-MS/MS method for determination of quetiapine in human plasma. J Pharmacol Biomed Anal 2007; 44: 498-505.
  26. http: ww.biomedsearch.com/nih Metabolism-active-metabolite-quetiapine-N/22688609.html.
  27. http://www.biomedsearch.com/nih/ Rapid-high-performanceliquid chromatographic/6124529. html.
  28. http://www.shvoong.com/medicine-and-health/1612945-simultaneous-determination-quetiapine-metabolites-human.
  29. Bakken G.V., Rudberg I., Christensen H., Molden E., Refsum H., Hermann M. Metabolism of quetiapine by CYP3А4 and CYP3А5 in Presence or Absence of Cytochrome B5. Drug Metabol Dispos 2009; 37: 2: 254-258.
  30. Lik Y., Cheng Z.-N., Li H.-D. Metabolic mechanism of quetiapine in vivo with clinical therapeutic dose. Exp Clin Pharmacol 2005; 27: 2: 83-87.
  31. Shen-Nan tin, Yan Chang, Moody D.E., Foltz R.T. A Liquid chromatographic-electrospray-tandem mass spectrometric method for quantitation of Quetiapine in human plasma and liver microsomes:application to a study of in vitro metabolism. J Analyt Toxicol 2004; 28: 6: 443-449.
  32. Stephens B.G., Coleman D.E., Baselt R.C. Olanzapine - Related Fatality. J Forens Sci 1998; 43: 6: 1252-1253.
  33. Robertson M.D., McMullin M.M. Olanzapine concentrations in clinical serum and postmortem blood specimes - when does therapeutic become toxic? J Forens Sci 2000; 45: 2: 418-421.
  34. Jenkins A.J., Sarkoni K.M., Raaf H.N. Determination of olanzapine in a postmortem case. J Anal Toxicol 1998; 22: 7: 605-609.
  35. Horak E.L., Jenkins A.J. Postmortem Tissue Distribution of Olanzapine and Citalopram in a Drug Intpxication. J Forens Sci 2005; 50: 3: 1-3.
  36. Vance C., McIntyre I.M. Postmortem Tissue Concentrations of Olanzapine. J Analit Toxicol 2009; 33: 1: 15-26.
  37. Сhue P., Singer P. A review of olanzapine-associated toxicity and fatality in overdose. J Psychiatr Neurosci 2003; 28: 4: 253-261.
  38. Nielsen M.K.K., Johansen S.S. Determination of Olanzapine in Whole Blood Using Simple Protein Precipitation and Liquid Chroumatography-Tandem Mass Spectrometry. J Analyt Toxicol 2009; 33: 4: 212-217.
  39. Zhang G., Terri A.V., Barlett M.G. Liquid Chroumatography/Tandem Masqs Spektrometriy Method for the Simultaneous Determination of Olanzapine, Risperidone, 9-hydroxyrisperidone, Closapine, Haloperidol and Ziprasidone in Rat Plasma. Rapid Commun Mass Spectrom 2007; 21: 6: 920-928.
  40. http://www.lookfordiagnosis.com/cases.php?term=Postmjrtem+Chages&filter=analisis%7Celement&values=0.006005%C0.003117&lang=1.
  41. Elean A.A. Fatal overdose of olanzapine. Forensic. Sci Int 1998; 91: 3: 231-235.
  42. Catlow J.T., Clemens R.D., Gillespie T.A., Goodwin M., Swanson S.P. Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid chromatography with electrochemical detection. J. Chromatogr B Biomed Appl 1995; 668: 1: 85-90.
  43. Bogusz M.J., Kruger K.D., Maier R.D., Erkwoch R., Tuchtenhagen F. Monitoring of olanzapine in serum by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. J Chromatog B: Biomed Sci Appl 1999; 732: 2: 257-269.
  44. Sven U. Assay of Olanzapine in Human Plasma by a Rapid and Sensitive Gas Chromatography-Nitrogen Phosphorus Selektive Detection (GC-NPD) Metod: Validation and Comparison With High-Performance Liquid Chromatography-Coulometric Detection. Terap Drug Monitor 2005; 27: 4: 463-468.
  45. Murphy A.T., Lake B.G., Bernstein J.R.,Franklin R.B., Gillespie T.A. Characterization of olanzapine (LY170053) in human liver slices by liquid chromatography/tandem mass spectrometry. J Mass Spectrom 1998; 33: 12: 1237-1245.
  46. Kassahun K., Mattiuz E., Franclin R., Gillespie T. Olanzapine 10-N-Glucuronide. Drug Metabol Dispos 1998; 26: 9: 848-855.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.